Evnia ๐ถ๐ ๐ฎ ๐๐ถ๐น๐๐ฒ๐ฟ ๐๐ฝ๐ผ๐ป๐๐ผ๐ฟ ๐ณ๐ผ๐ฟย ๐๐ผ๐ฟ๐ถ๐๐ผ๐ป ๐ฎ๐ฌ๐ฎ๐ฐ: ๐๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐๐ป๐๐ฒ๐๐๐ถ๐ด๐ฎ๐๐ถ๐ผ๐ป๐, ๐ฅ๐ฒ๐ด๐๐น๐ฎ๐๐ถ๐ผ๐ป ๐ฎ๐ป๐ฑ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐๐ฐ๐ฐ๐ฒ๐๐ ๐ณ๐ผ๐ฟ ๐ ๐ฒ๐ฑ๐ถ๐ฐ๐ฎ๐น ๐๐ฒ๐๐ถ๐ฐ๐ฒ๐ ๐ฎ๐ป๐ฑ ๐๐ฉ๐๐!
๐ Copenhagen, Denmark
๐ 20-21 November 2024
The conference, chaired by RQM+’s Amie Smirthwaite, PhD, FRAPS will examine the interplay between regulatory science, demonstration of device safety and performance, and development of an effective pre-and post-market clinical evidence strategy. It will also address critical operational issues including data management, statistics, cost-effective study design, outsourcing, reimbursement planning, and more!
Some of the top clinical, regulatory, and industry experts in Europe are attending!
We are looking forward to meeting you in person!
